Spots Global Cancer Trial Database for Expanded Access RBS2418 Treatment
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Expanded Access RBS2418 Treatment
Official Title: Expanded Access to RBS2418 for an Individual Patient With Pancreatic Cancer
Study ID: NCT05683470
Conditions
Interventions
Study Description
Brief Summary: This is an expanded access treatment protocol designed to provide access of RBS2418 to a single patient with pancreatic cancer.
Detailed Description: Given lack of any therapeutic options such as standard of care chemotherapy for this single patient owing to lack of tolerability and opportunity to enroll in any clinical trial due to extent of disease, patient desires to try compassionate use protocol with RBS2418, an oral immunotherapeutic agent that is currently in clinical trials and is well tolerated by patients. Furthermore, patient's tumor has been shown to express ENPP1, the protein targeted by RBS2418
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Contact Details
Name: Bertrand Tuan, MD
Affiliation: Pacific Hematology and Oncology Associates
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
